1. Home
  2. KITT vs VBIO Comparison

KITT vs VBIO Comparison

Compare KITT & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITT

Nauticus Robotics Inc.

HOLD

Current Price

$1.38

Market Cap

2.4M

Sector

Industrials

ML Signal

HOLD

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

HOLD

Current Price

$1.64

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KITT
VBIO
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
KITT
VBIO
Price
$1.38
$1.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
460.4K
★ 688.0K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 71.55
N/A
EPS
★ N/A
N/A
Revenue
★ $11,434,959.00
$780,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 33.10
N/A
52 Week Low
$0.39
$0.12
52 Week High
$3.51
$812.50

Technical Indicators

Market Signals
Indicator
KITT
VBIO
Relative Strength Index (RSI) 54.62 23.18
Support Level $0.63 $0.12
Resistance Level $2.08 $4.39
Average True Range (ATR) 0.24 0.49
MACD -0.00 3.74
Stochastic Oscillator 32.93 1.79

Price Performance

Historical Comparison
KITT
VBIO

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc is a technology-driven company specializing in the development of fully electric autonomous robotic solutions for subsea applications. Its portfolio includes autonomous underwater vehicles (AUVs), electric robotic manipulators, a platform-agnostic robotic operating system, and related engineering, consulting and prototype services. The Company's solutions enable autonomous operations for both commercial and defense sectors, with alignment to offshore energy and national security interests. Its addressable markets include upstream, midstream and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research and subsea mining, with current focus on oil and gas operations and defense applications.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: